The Trump administration has sparked debate by proposing restrictions on one medication linked to autism, while advocating for broader access to another under investigation. What does this mean for future healthcare decisions?
After years of debilitating pain from rheumatoid arthritis, Lynn Milam found relief with an experimental device that stimulates the vagus nerve. This FDA-approved implant could transform the lives of many suffering from autoimmune diseases.
In a remarkable turn of events, 8-year-old Nathaniel Schumann, who was nonverbal, began to speak in full sentences just two weeks after starting a clinical trial for an autism treatment. This development raises hopes for many families.
Merck's new injectable cancer drug, Keytruda Qlex, promises to transform patient treatment with a quick administration time and flexible dosing, all while maintaining effectiveness. Available in late September, this shift is critical as the market braces for biosimilar competition.
Logitech unveils the G Pro X2 Superstrike, a revolutionary esports mouse that replaces traditional clicks with haptic feedback for ultra-fast response times. Discover its game-changing features and performance!
Discover the groundbreaking Superstrike mouse, featuring state-of-the-art analog sensors and haptic feedback for an unparalleled gaming experience. Are you ready to elevate your gameplay?
Isabel Kallman grapples with perimenopause symptoms and the decision to consider hormone therapy. Experts argue that the risks associated with treatment may have been overstated, calling for a reevaluation of FDA warnings.
In Manchester, scientists are divided over the implications of 'mirror life' research, which could lead to synthetic cells with mirror-image molecules. While some see potential benefits, others warn of significant health and environmental risks.
New research reveals that chronic insomnia not only leads to fatigue but also increases the risk of cognitive decline by 40%. Discover how treating insomnia can potentially safeguard your brain health as you age!
Elissa Kalver, diagnosed with HER2-positive metastatic breast cancer at 34, shares her inspiring journey through aggressive treatments, clinical trials, and living life to the fullest despite her diagnosis.
